1 of 1
SENATE DOCKET, NO. 1886 FILED ON: 1/20/2023
SENATE . . . . . . . . . . . . . . No. 1430
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
Michael O. Moore
_________________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
An Act relative to hormonal contraceptives.
_______________
PETITION OF:
NAME:DISTRICT/ADDRESS :Michael O. MooreSecond WorcesterVanna Howard17th Middlesex2/28/2023Rebecca L. RauschNorfolk, Worcester and Middlesex3/8/2023 1 of 3
SENATE DOCKET, NO. 1886 FILED ON: 1/20/2023
SENATE . . . . . . . . . . . . . . No. 1430
By Mr. Moore, a petition (accompanied by bill, Senate, No. 1430) of Michael O. Moore, Vanna
Howard and Rebecca L. Rausch for legislation relative to hormonal contraceptives. Public
Health.
[SIMILAR MATTER FILED IN PREVIOUS SESSION
SEE SENATE, NO. 1487 OF 2021-2022.]
The Commonwealth of Massachusetts
_______________
In the One Hundred and Ninety-Third General Court
(2023-2024)
_______________
An Act relative to hormonal contraceptives.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority
of the same, as follows:
1 SECTION 1. Chapter 94C, as appearing in the 2020 Official Edition, is hereby amended
2by inserting, after section 19D, the following section:-
3 Section 19E. A registered pharmacist may prescribe and dispense hormonal contraceptive
4patches and self-administered oral hormonal contraceptives to a person who is:
5 (a) At least 18 years of age, regardless of whether the person has evidence of a previous
6prescription from a primary care practitioner or women’s health care practitioner for a hormonal
7contraceptive patch or self-administered oral hormonal contraceptive; or 2 of 3
8 (b) Under 18 years of age, only if the person has evidence of a previous prescription from
9a primary care practitioner or women’s health care practitioner for a hormonal contraceptive
10patch or self-administered oral hormonal contraceptive.
11 The board shall adopt rules to establish, in consultation with the Massachusetts Medical
12Board, the Massachusetts State Board of Nursing and the MassHealth, and in consideration of
13guidelines established by the American Congress of Obstetricians and Gynecologists, standard
14procedures for the prescribing of hormonal contraceptive patches and self-administered oral
15hormonal contraceptives by pharmacists. The rules adopted under this subsection must require a
16pharmacist to:
17 (a) Complete a training program approved by the State Board of Pharmacy that is related
18to prescribing hormonal contraceptive patches and self-administered oral hormonal
19contraceptives;
20 (b) Provide a self-screening risk assessment tool that the patient must use prior to the
21pharmacist’s prescribing the hormonal contraceptive patch or self-administered oral hormonal
22contraceptive;
23 (c) Refer the patient to the patient’s primary care practitioner or women’s health care
24practitioner upon prescribing and dispensing the hormonal contraceptive patch or self-
25administered oral hormonal contraceptive;
26 (d) Provide the patient with a written record of the hormonal contraceptive patch or self-
27administered oral hormonal contraceptive prescribed and dispensed and advise the patient to
28consult with a primary care practitioner or women’s health care practitioner; and 3 of 3
29 (e) Dispense the hormonal contraceptive patch or self-administered oral hormonal
30contraceptive to the patient as soon as practicable after the pharmacist issues the prescription.
31 The rules adopted must prohibit a pharmacist from:
32 (a) Requiring a patient to schedule an appointment with the pharmacist for the
33prescribing or dispensing of a hormonal contraceptive patch or self-administered oral hormonal
34contraceptive; and
35 (b) Prescribing and dispensing a hormonal contraceptive patch or self-administered oral
36hormonal contraceptive to a patient who does not have evidence of a clinical visit for women’s
37health within the three years immediately following the initial prescription and dispensation of a
38hormonal contraceptive patch or self-administered oral hormonal contraceptive by a pharmacist
39to the patient.